Literature DB >> 3488416

Mutation in the VP-1 gene is responsible for the extended host range of a monkey B-lymphotropic papovavirus mutant capable of growing in T-lymphoblastoid cells.

T Kanda, A Furuno, K Yoshiike.   

Abstract

Monkey B-lymphotropic papovavirus (LPV) replicates only in B-lymphoblastoid cells, whereas the LPV mutant 76 (LPV-76) can grow in either B- or T-lymphoblastoid cells. The nucleotide sequence of the wild-type LPV PstI B segment was compared with that of LPV-76 PstI-B, within which the mutation responsible for the extended host range had been located. The VP-1 coding region of LPV-76 was found to have mutations, single-base substitutions causing three amino acid substitutions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488416      PMCID: PMC253110          DOI: 10.1128/JVI.59.2.531-534.1986

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia.

Authors:  B I Sahai Srivastava; J Minowada
Journal:  Biochem Biophys Res Commun       Date:  1973-04-02       Impact factor: 3.575

2.  Alignment of the genome of monkey B-lymphotropic papovavirus to the genomes of simian virus 40 and BK virus.

Authors:  T Kanda; K Yoshiike; K K Takemoto
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

3.  Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA.

Authors:  L Brade; W Vogl; L Gissman; H zur Hausen
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

4.  Lymphotropic papovaviruses isolated from African green monkey and human cells.

Authors:  H zur Hausen; L Gissmann
Journal:  Med Microbiol Immunol       Date:  1979-08       Impact factor: 3.402

5.  Biological and biochemical studies of African green monkey lymphotropic papovavirus.

Authors:  K K Takemoto; A Furuno; K Kato; K Yoshiike
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

6.  Identification of B-lymphotropic papovavirus-coded proteins.

Authors:  K Segawa; K K Takemoto
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  B-lymphotropic papovavirus and possibility of infections in humans.

Authors:  L Brade; N Müller-Lantzsch; H zur Hausen
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus.

Authors:  M Pawlita; A Clad; H zur Hausen
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).

Authors:  Y Hayashi; Y Matsumura; T Nishihira; I Watanabe; R Ohi; M Kasai; K Kumagai; N Kamada
Journal:  Jpn J Exp Med       Date:  1980-12
View more
  4 in total

1.  Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia.

Authors:  J D Chen; K Neilson; T Van Dyke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.

Authors:  R Freund; A Calderone; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Structures of B-lymphotropic polyomavirus VP1 in complex with oligosaccharide ligands.

Authors:  Ursula Neu; Zaigham Mahmood Khan; Benjamin Schuch; Angelina S Palma; Yan Liu; Michael Pawlita; Ten Feizi; Thilo Stehle
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

4.  Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity.

Authors:  Michael H C Buch; A Manuel Liaci; Samantha D O'Hara; Robert L Garcea; Ursula Neu; Thilo Stehle
Journal:  PLoS Pathog       Date:  2015-10-16       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.